ZRANB1 and neoplasm: Based on molecular mechanism related assays, we concluded that FAM83C-AS1 binding to ZRANB1 promoted EZH2 deubiquitination and thereby inhibited EZH2 downregulation, which led to the enhanced protein stability of EZH2 in CRC tumor cells.